Trial
NCT05922995
The Effects of Tasimelteon in Participants With REM Behavior Disorder (RBD)
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Brigham and Women's Hospital
Collaborators
Vanda Pharmaceuticals
Condition
REM Behavior Disorder
Intervention
Tasimelteon
Why stopped
Study will not longer be done. Terminated due to sponsor noncompliance.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-09